Occupational and industry prevalence of new long‐term symptoms within American Red Cross blood donors with and without history of SARS‐CoV‐2 infection
Deja Edwards, Sharon Saydah(Centers for Disease Control and Prevention), Bryan R. Spencer(American Red Cross), Nicole D. Ford(Centers for Disease Control and Prevention), Dallas S. Shi(National Institute for Occupational Safety and Health), Melisa M. Shah(Centers for Disease Control and Prevention), Jessica L. Rinsky(Centers for Disease Control and Prevention), James M. Haynes(American Red Cross), Jefferson M. Jones(National Center for Immunization and Respiratory Diseases)
Cited by 0
Related Papers
Obesity in Low- and Middle-Income Countries: Burden, Drivers, and Emerging Challenges
|Annual Review of Public Health|2017|535
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019
|MMWR Morbidity and Mortality Weekly Report|2022|442
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
|JAMA|2021|218
Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023
|MMWR Morbidity and Mortality Weekly Report|2023|173
Exposure to improved nutrition from conception to age 2 years and adult cardiometabolic disease risk: a modelling study
|The Lancet Global Health|2018|68